Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Limb Preservation Platform (LPP) is a specialized clinical research organization and freestanding wound care facility based in Fresno, California. Founded and led by Dr. Shawn Cazzell, the company focuses on the advancement of lower extremity wound management through Phase I-IV clinical trials. LPP partners with global pharmaceutical and biotechnology companies to evaluate novel therapeutics, including regenerative medicine products, medical devices, and topical drug candidates for chronic, non-healing wounds. The center integrates advanced clinical research with specialized patient care, serving as a key site for pivotal trials in diabetic foot ulcers and venous leg ulcers. By providing high-quality clinical data and access to cutting-edge treatments, LPP plays a critical role in the development of limb-salvage therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Limb Preservation Platform.